ArticleBMJ open2022

Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP).

David Ekqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.